SCHEUERMANN + HEILIG GmbH
Is this your company? Claim this profile
Drug Product
Manufacturing & Lab Equipment
Company Overview
About
SCHEUERMANN + HEILIG GmbH is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Germany
Founded:2012
Employees:3,085
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval 6J41SZ
EMA · #APR-X01UPYN6 · 2021-04-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-8UOP8NM4
Issued: 2020-10-12
Expires: 2025-05-24
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-ZC5MKTNA
Issued: 2020-03-06
Expires: 2025-06-16
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-BLA32YZ1
Issued: 2020-12-07
Expires: 2025-10-12
WHO GMP
World Health Organization
Cert #: CERT-6KDKMAN0
Issued: 2020-02-03
Expires: 2025-02-16
Loading CDMO intelligence...
Key facts about SCHEUERMANN + HEILIG GmbH
- SCHEUERMANN + HEILIG GmbH is headquartered in Germany.
- SCHEUERMANN + HEILIG GmbH was founded in 2012.
- SCHEUERMANN + HEILIG GmbH has 3,085 employees.
- SCHEUERMANN + HEILIG GmbH's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like SCHEUERMANN + HEILIG GmbH
Directory pages this company appears in, each with the full list of matching manufacturers.